A Director at Zogenix is Exercising Options

By Carrie Williams

Today, a Director at Zogenix, Cam Garner , exercised options of Zogenix (NASDAQ: ZGNX) for $8,698.

Following Cam Garner’s last ZGNX Sell transaction on June 16, 2014, the stock climbed by 25.9%. This is Garner’s first Sell trade following 3 Buy transactions.

See today’s analyst top recommended stocks >>

Currently, Zogenix has an average volume of 705K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Zogenix, Inc. is a pharmaceutical company, which engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. It develops two products candidate: ZX008 and Relday.